AI-powered analysis of multianalyte liquid biopsies could be an accessible way to improve ovarian cancer screening.

The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.

With rising rates of colorectal cancers in younger people, UCSF experts tell you that getting screened for cancer may be as ...

Knowles' journey began nearly five years ago when, in a moment of keen self-awareness that would make headlines.

Mathew Knowles is using his personal experience with breast cancer to help raise awareness among men. He recently joined ...

Those involved with September's ovarian cancer awareness campaign are preparing to shift their focus to October's breast ...

If you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of ...

Genetic testing is used to weigh a person's risk of developing cancer. Researchers are hoping to expand care through chatbot ...

CEO Katherine Stueland discusses company’s pivot to whole exome sequencing, whole genome sequencing tests for children with GEN Edge.

Casitas B-lineage lymphoma b (Cbl/b) is an E3 ubiquitin ligase that has been shown to be a key regulator of the activation of T and natural killer (NK) cells in the absence of CD28 costimulation GRC ...

Those involved with September’s ovarian cancer awareness campaign are preparing to shift their focus to October’s breast ...

Medicare may provide coverage for genetic testing when it is medically necessary for a diagnosis or treatment. Learn more ...